These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38659945)

  • 1. Proinflammatory stress activates neutral sphingomyelinase 2 based generation of a ceramide-enriched β cell EV subpopulation.
    Xu J; Harris-Kawano A; Enriquez JR; Mirmira RG; Sims EK
    bioRxiv; 2024 Apr; ():. PubMed ID: 38659945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes.
    Lakhter AJ; Pratt RE; Moore RE; Doucette KK; Maier BF; DiMeglio LA; Sims EK
    Diabetologia; 2018 May; 61(5):1124-1134. PubMed ID: 29445851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nipping disease in the bud: nSMase2 inhibitors as therapeutics in extracellular vesicle-mediated diseases.
    Tallon C; Hollinger KR; Pal A; Bell BJ; Rais R; Tsukamoto T; Witwer KW; Haughey NJ; Slusher BS
    Drug Discov Today; 2021 Jul; 26(7):1656-1668. PubMed ID: 33798648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal deletion of nSMase2 reduces the production of Aβ and directly protects neurons.
    Tohumeken S; Deme P; Yoo SW; Gupta S; Rais R; Slusher BS; Haughey NJ
    Neurobiol Dis; 2023 Feb; 177():105987. PubMed ID: 36603748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of nSMase2 Reduces the Transfer of Oligomeric α-Synuclein Irrespective of Hypoxia.
    Sackmann V; Sinha MS; Sackmann C; Civitelli L; Bergström J; Ansell-Schultz A; Hallbeck M
    Front Mol Neurosci; 2019; 12():200. PubMed ID: 31555088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury.
    Tallon C; Picciolini S; Yoo SW; Thomas AG; Pal A; Alt J; Carlomagno C; Gualerzi A; Rais R; Haughey NJ; Bedoni M; Slusher BS
    Biochem Pharmacol; 2021 Dec; 194():114796. PubMed ID: 34678224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of neutral sphingomyelinase 2 through hyperglycemia contributes to endothelial apoptosis via vesicle-bound intercellular transfer of ceramides.
    Zietzer A; Jahnel AL; Bulic M; Gutbrod K; Düsing P; Hosen MR; Dörmann P; Werner N; Nickenig G; Jansen F
    Cell Mol Life Sci; 2021 Dec; 79(1):48. PubMed ID: 34951654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulated translocation of neutral sphingomyelinase-2 to the plasma membrane drives insulin resistance in steatotic hepatocytes.
    El-Amouri S; Karakashian A; Bieberich E; Nikolova-Karakashian M
    J Lipid Res; 2023 Oct; 64(10):100435. PubMed ID: 37640282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in murine Alzheimer's disease.
    Tallon C; Bell BJ; Malvankar MM; Deme P; Nogueras-Ortiz C; Eren E; Thomas AG; Hollinger KR; Pal A; Mustapic M; Huang M; Coleman K; Joe TR; Rais R; Haughey NJ; Kapogiannis D; Slusher BS
    Res Sq; 2023 Jul; ():. PubMed ID: 37502930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting tau-induced elevated nSMase2 activity and ceramides is therapeutic in an Alzheimer's disease mouse model.
    Tallon C; Bell BJ; Malvankar MM; Deme P; Nogueras-Ortiz C; Eren E; Thomas AG; Hollinger KR; Pal A; Mustapic M; Huang M; Coleman K; Joe TR; Rais R; Haughey NJ; Kapogiannis D; Slusher BS
    Transl Neurodegener; 2023 Dec; 12(1):56. PubMed ID: 38049923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties.
    Figuera-Losada M; Stathis M; Dorskind JM; Thomas AG; Bandaru VV; Yoo SW; Westwood NJ; Rogers GW; McArthur JC; Haughey NJ; Slusher BS; Rojas C
    PLoS One; 2015; 10(5):e0124481. PubMed ID: 26010541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi.
    Gu L; Huang B; Shen W; Gao L; Ding Z; Wu H; Guo J
    J Neuroinflammation; 2013 Sep; 10():109. PubMed ID: 24007266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIV Infection Regulates Compartmentalization of Circulating Blood Plasma miRNAs within Extracellular Vesicles (EVs) and Extracellular Condensates (ECs) and Decreases EV-Associated miRNA-128.
    Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992331
    [No Abstract]   [Full Text] [Related]  

  • 14. A signaling cascade mediated by ceramide, src and PDGFRβ coordinates the activation of the redox-sensitive neutral sphingomyelinase-2 and sphingosine kinase-1.
    Cinq-Frais C; Coatrieux C; Grazide MH; Hannun YA; Nègre-Salvayre A; Salvayre R; Augé N
    Biochim Biophys Acta; 2013 Aug; 1831(8):1344-56. PubMed ID: 23651497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA Damage Regulates Senescence-Associated Extracellular Vesicle Release via the Ceramide Pathway to Prevent Excessive Inflammatory Responses.
    Hitomi K; Okada R; Loo TM; Miyata K; Nakamura AJ; Takahashi A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32466233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutral Sphingomyelinase 2 Mediates Oxidative Stress Effects on Astrocyte Senescence and Synaptic Plasticity Transcripts.
    Zhu Z; Quadri Z; Crivelli SM; Elsherbini A; Zhang L; Tripathi P; Qin H; Roush E; Spassieva SD; Nikolova-Karakashian M; McClintock TS; Bieberich E
    Mol Neurobiol; 2022 May; 59(5):3233-3253. PubMed ID: 35294731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VAP-A and its binding partner CERT drive biogenesis of RNA-containing extracellular vesicles at ER membrane contact sites.
    Barman B; Sung BH; Krystofiak E; Ping J; Ramirez M; Millis B; Allen R; Prasad N; Chetyrkin S; Calcutt MW; Vickers K; Patton JG; Liu Q; Weaver AM
    Dev Cell; 2022 Apr; 57(8):974-994.e8. PubMed ID: 35421371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Neutral Sphingomyelinase 2 by Novel Small Molecule Inhibitors Results in Decreased Release of Extracellular Vesicles by Vascular Smooth Muscle Cells and Attenuated Calcification.
    Pavlic A; Poelman H; Wasilewski G; Wichapong K; Lux P; Maassen C; Lutgens E; Schurgers LJ; Reutelingsperger CP; Nicolaes GAF
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src regulates cigarette smoke-induced ceramide generation via neutral sphingomyelinase 2 in the airway epithelium.
    Chung S; Vu S; Filosto S; Goldkorn T
    Am J Respir Cell Mol Biol; 2015 Jun; 52(6):738-48. PubMed ID: 25347576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceramide synthesis regulates biogenesis and packaging of exosomal MALAT1 from adipose derived stem cells, increases dermal fibroblast migration and mitochondrial function.
    Kong X; Patel NA; Chalfant CE; Cooper DR
    Cell Commun Signal; 2023 Aug; 21(1):221. PubMed ID: 37620957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.